Literature DB >> 23742998

Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle.

Maki Nishimura1, Junko Kohara, Yasuhiro Kuroda, Jun Hiasa, Sachi Tanaka, Yoshikage Muroi, Naoya Kojima, Hidefumi Furuoka, Yoshifumi Nishikawa.   

Abstract

Neospora caninum is an intracellular protozoan parasite that causes abortion in cows. Vaccination is an important strategy for control of neosporosis, and a safe and effective vaccine suitable for cattle is required. Dense granule protein 7 of N. caninum (NcGRA7) is a secretory protein with high antigenicity in hosts. We demonstrated previously that NcGRA7 entrapped in liposomes coated with mannotriose (M3-NcGRA7) could induce a parasite-specific T-helper type 1 immune response and produce humoral antibodies that resulted in increased offspring survival and decreased infection in the brains of mice dams. In the present study, the efficacy of M3-NcGRA7 as a vaccine candidate against N. caninum has been evaluated in cattle (n=12). Cattle were immunized with M3-NcGRA7 containing 50 μg (n=4) or 200 μg NcGRA7 (n=4) subcutaneously twice with a 4-week interval and all cattle including the non-immunized controls (n=4) were inoculated with 10(7) tachyzoites of Nc-1 strain 27 days after the second immunization and euthanized at 85-87 days post infection (dpi). In immunized cattle, NcGRA7-specific antibody production and IFN-γ production in PBMC was induced before challenge. At 3 dpi, body temperature and concentration of serum IFN-γ tended to be higher in control cattle than in the immunized cattle. Furthermore, the parasite load in the brain significantly decreased in cattle immunized with 50 μg M3-NcGRA7 compared with controls. These results suggest that M3-NcGRA7 can induce protective immune responses to N. caninum tachyzoites in cattle, which could lead to practical application of safe and effective subunit vaccines.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cattle; Dense granule protein 7; Neospora caninum; Oligomannose-coated liposome; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 23742998     DOI: 10.1016/j.vaccine.2013.05.083

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Liposomes as vaccine delivery systems: a review of the recent advances.

Authors:  Reto A Schwendener
Journal:  Ther Adv Vaccines       Date:  2014-11

2.  Bombyx mori nucleopolyhedrovirus displaying neospora caninum antigens as a vaccine candidate against N. caninum infection in mice.

Authors:  Tatsuya Kato; Takahiro Otsuki; Mai Yoshimoto; Kohei Itagaki; Tetsuya Kohsaka; Yumino Matsumoto; Kazunori Ike; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

3.  Transcriptome and histopathological changes in mouse brain infected with Neospora caninum.

Authors:  Maki Nishimura; Sachi Tanaka; Fumiaki Ihara; Yoshikage Muroi; Junya Yamagishi; Hidefumi Furuoka; Yutaka Suzuki; Yoshifumi Nishikawa
Journal:  Sci Rep       Date:  2015-01-21       Impact factor: 4.379

4.  Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.

Authors:  Mohamad Alaa Terkawi; Yasuhiro Kuroda; Shinya Fukumoto; Sachi Tanaka; Naoya Kojima; Yoshifumi Nishikawa
Journal:  Malar J       Date:  2014-11-05       Impact factor: 2.979

Review 5.  Towards a preventive strategy for neosporosis: challenges and future perspectives for vaccine development against infection with Neospora caninum.

Authors:  Yoshifumi Nishikawa
Journal:  J Vet Med Sci       Date:  2017-07-07       Impact factor: 1.267

6.  Immune Protective Evaluation Elicited by DNA Vaccination With Neospora caninum Dense Granules Proteins in Mice.

Authors:  Guili Yu; Wei Liang; Qiankun Yang; Jinxin Wang; Yu Wang; Tianmeng Zhang; Xiao Zhang; Hui Fan; Panpan Zhao; Lili Cao; Jingquan Dong
Journal:  Front Vet Sci       Date:  2021-02-26

7.  Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3.

Authors:  Kyosuke Senchi; Satoko Matsunaga; Hideki Hasegawa; Hirokazu Kimura; Akihide Ryo
Journal:  Front Microbiol       Date:  2013-11-26       Impact factor: 5.640

Review 8.  Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.

Authors:  Naoya Kojima; Mariko Ishii; Yoko Kawauchi; Hideaki Takagi
Journal:  Biomed Res Int       Date:  2013-10-10       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.